Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Auriga Maintains a 'Buy' on Globe Specialty Metals (GSM); Revising Numbers After In-line Results
-
Auriga on Technology Hardware: EMC Officially Launching "Project Lightning" = Game on in PCIe SSDs
-
Auriga Reiterates a 'Buy' on Haynes International (HAYN); F1Q12 Shortfall Driven by Production Delays, F2Q12 Remains on Track
-
Auriga Maintains a 'Buy' on DepoMed (DEPO); Janumet XR Launch should boost Royalty Income in 2012
-
Auriga Reiterates a 'Buy' on Medifast (MED); Management Change Shouldn't Alter 2012 Plans
-
Auriga Cuts EPS Estimates on Columbia Sportswear (COLM); Decent Q4, But See Tough Year Ahead
-
Auriga on Solar Photovoltaics: Job Losses from Import Tariffs on Chinese Solar cell/modules Make No CASE
-
Auriga Reiterates a 'Buy' on Thermo Fisher Scientific (TMO); Year Ends on Strong Note; 2012 Guidance Looks Good
-
Auriga on Nutrisystem (NTRI); Shares Remain Cheap - Despite New Promotion, Prices Above Last Year
-
Streetinsider.com's Hot Lunchtime Reads 02/01: (GM) (BRCM) (AMZN) (KWK) (KO) (STX)
-
Auriga Reiterates a 'Buy' on Myriad Genetics (MYGN); F2Q12 Results: Nice Beat & Raise as Colaris Continues to Surprise
-
Auriga Maintains a 'Buy' on Intevac (IVAC); Remains a Wait-and-See Story; Reducing Estimates & PT
-
Auriga Reiterates a 'Buy' on Seagate Technology (STX); Beats Twice Raised Estimates; Massively Guides Up
-
UPDATE - Auriga Downgraded Broadcom (BRCM) to Hold; Valuation Call Despite 'Beat & Raise'
-
Auriga Downgrades Broadcom (BRCM) to Hold
-
Auriga on Solar Power/CleanTech: U.S. Shows China the Writing on the Tariff Wall With "Critical Circumstances"
-
Auriga on Hardware: HDD Earnings on Tap - Further Upside Possible for Seagate; Wait & See Outlook Expected for Intevac
-
Auriga maintains a 'Buy' on Marvell (MRVL); Cuts N-T Estimates, But Expect Growth To Resume In 1FQ13
-
Auriga Maintains a 'Buy' on Globe Specialty Metals (GSM); Lowering Q2, But Demand Improving as Plant Resumes Production
-
Auriga Maintains a 'Hold' on Columbia Sportswear (COLM); Cutting Q4 & FY12 Estimates Ahead of Report
-
Auriga Reiterates a 'Buy' on McKesson (MCK); Center Stage of Strong Qtr Include Katz Acquisition and Increased Buyback
-
Auriga Reiterates a 'Buy' on Computer Programs and Systems (CPSI); Showing Hospitals the Money
-
Auriga Reiterates a 'Buy' on Sequenom (SQNM); Raising Estimated T21 Test Volumes for 2012
-
Auriga Reiterates a 'Buy' on Universal Stainless & Alloy (USAP); Raising PT on Solid Qtr; Backlog Reaches New Peak
-
Auriga Reiterates a 'Buy' on Weight Watchers (WTW); Raising Numbers on Expected Sustained Growth from PointsPlus
-
Auriga Reiterates a 'Buy' on Carpenter Technology (CRS); Ongoing Mix Improvement Initiatives Drive EPS Surprise
-
Auriga Reiterates a 'Buy' on Celgene (CELG); Uneventful Q4 Call; Upsides from Multiple Catalysts in 2012
-
Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Share Price Decline Unwarranted; Fundamentals Remain Strong
-
Auriga Maintains a 'Hold' on Quality Systems (QSII); In-line Quarter, Few Surprises (This Time)
-
Auriga Reiterates a 'Buy' on Omnicell (OMCL); Backlog Disappoints While Margins on Track
-
Auriga Reiterates a 'Hold' on Under Armour, Inc. (UA); Growth in Profitability Not Expected Until 2H12
-
Auriga Maintains a 'Hold' on Riverbed Technology (RVBD); Sidelined on Product Transition Issues
-
Auriga Downgrades Juniper Networks (JNPR) to Hold After Another Guidance Cut
-
Streetinsider.com's Hot Lunchtime Reads 01/26: (JPM) (SGEN) (ATI) (V) (IPHI) (SAP)
-
Auriga Maintains a 'Buy' on Allegheny Technologies (ATI); Stainless Drives EPS Shortfall; Adjusting Forward Estimates & PT
-
UPDATE - Auriga Downgraded HCA Holdings (HCA) to Hold; Macro Issues Moderate, But Still Present Over Next 12 Months
-
Notable Analyst Rating Changes 01/26: (DAL) (NVDA) (STJ) Upgraded; (GLW) (STI) (CHK) Downgraded
-
Auriga Starts CareFusion (CFN) at Buy; More Care and Less "ConFusion"
-
Auriga Downgrades HCA Holdings (HCA) to Hold
-
Investors, Analysts Consider Roche's Bid for Illumina (ILMN) Too Low
-
Streetinsider.com's Hot Lunchtime Reads 01/25: (AAPL) (NOK) (ILMN) (JCP) (GM) (BAC) (JNJ)
-
Auriga Reiterates a 'Sell' on Fusion-io (FIO); Solid Revenue, but Earnings Outlook Disappoints
-
Auriga Reiterates a 'Buy' on Illumina (ILMN); Roche Goes Hostile - Likely Only An Opening Offer
-
Auriga Reiterates a 'Hold' on Quest Diagnostics (DGX); 4Q11: A Solid Quarter with Cost Management Highlighted
-
Auriga Reiterates a 'Buy' on Waters Corp. (WAT); 4Q11 Review: Good End to 2011; 2012 Outlook Realistically Conservative
-
Auriga Maintains a 'Buy' on Nutrisystem (NTRI); Recent Pullback Presents Opportunity
-
Auriga Reiterates a 'Buy' on Crane (CR); Solid Year Overall But 4Q Expectations Fall Short of Lofty Expectations
-
Auriga Reiterates a 'Buy' on EMC (EMC); Delivers Strong Share Gain Driven Upside;
-
Auriga Maintains a 'Hold' on Altera (ALTR); Surprisingly Weak Guidance is Likely the Bottom
-
Auriga Boosts Price Target on Apple (AAPL) to $650

